세계의 투약 관리 시장 : 소프트웨어별, 서비스별, 제공 모드별, 최종사용자별, 지역별(2025-2033년)

The global medication management market size reached USD 3.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.13% during 2025-2033. The increasing investments by healthcare facilities in improving operational efficiency and workflow are stimulating the market.

Medical management includes monitoring, medication reconciliation, and ensuring that patients achieve their desired results by designing treatment plans and supervising their safety and effectiveness. As part of the process, patients and their caregivers are educated and engaged about safety and adherence concerns about medications as well as adverse drug events. A medication management system, which is included in healthcare reform, enhances inventory management, dispensing of medicines, and the control of adverse drug events (ADE). Additionally, it suggests reminder and organization tools that are most comfortable for patients, leading to a significant improvement in both patient outcomes and safety. Utilizing medication management services correctly reduces the prevalence of disease and mortality rates, thereby making healthcare safer and more reliable.

Medication Management Market Trends:

The market is majorly driven by a considerable rise in investments by healthcare facilities to improve workflow and operational efficiency. This can be attributed to the escalating need to minimize medication errors and healthcare expenditures. In addition to this, the increased workload on healthcare providers for efficient management and preservation of the records is providing an impetus to the market. Moreover, the growing trend of automating workflow management solutions through the use of new technologies in the healthcare sector is resulting in a higher uptake of medication management solutions. The market is further propelled by the increasing geriatric population that is susceptible to numerous health conditions. Apart from this, an enhanced focus on value-based medicine is creating lucrative market opportunities for the key players. Some of the other factors contributing to the market include the growing prevalence of numerous chronic illnesses, rapid advancements in medical technology, significant player mergers and acquisitions (M&As), rising healthcare expenditure and extensive research and development (R&D) activities.

Key Market Segmentation:

Breakup by Software:

• Computerized Physician Order Entry System
• Clinical Decision Support System
• Administration Software
• Electronic Medication Administration Record (EMAR) Software
• Barcode Medication Administration (BMA) Software
• Inventory Management System
• Automated Dispensing Systems
• Centralized Automated Dispensing Systems
• Robots/Robotic Automated Dispensing Systems
• Carousels
• Decentralized Automated Dispensing Systems (Ads)
• Pharmacy-Based Decentralized Automated Dispensing Systems
• Ward-Based Decentralized Automated Dispensing Systems
• Automated Unit-Dose Decentralized Automated Dispensing Systems
• Assurance System

Breakup by Services:

• Medication Analytics Services
• Point-Of-Care Verification Services
• Adverse Drug Event (ADE) Surveillance Services

Breakup by Mode of Delivery:

• Web-based
• Cloud-based
• On-premises

Breakup by End User:

• Pharmacies
• Hospitals
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Allscripts Healthcare Solutions Inc., ARxIUM Inc., Becton Dickinson and Company, BIQ Health Solutions, Cardinal Health Inc., Mckesson Corporation, Omnicell Inc., Optum Inc. (UnitedHealth Group Incorporated), Oracle Corporation and Talyst LLC (Swisslog Healthcare). Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

• 1.What was the size of the global medication management market in 2024?
• 2.What is the expected growth rate of the global medication management market during 2025-2033?
• 3.What are the key factors driving the global medication management market?
• 4.What has been the impact of COVID-19 on the global medication management market?
• 5.What is the breakup of the global medication management market based on the software?
• 6.What is the breakup of the global medication management market based on the services?
• 7.What is the breakup of the global medication management market based on the end user?
• 8.What are the key regions in the global medication management market?
• 9.Who are the key players/companies in the global medication management market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medication Management Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Software

• 6.1 Computerized Physician Order Entry System
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Clinical Decision Support System
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Administration Software
  • 6.3.1 Market Trends
  • 6.3.2 key Segments
    • 6.3.2.1 Electronic Medication Administration Record (EMAR) Software
    • 6.3.2.2 Barcode Medication Administration (BMA) Software
  • 6.3.3 Market Forecast
• 6.4 Inventory Management System
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Automated Dispensing Systems
  • 6.5.1 Market Trends
  • 6.5.2 key Segments
    • 6.5.2.1 Centralized Automated Dispensing Systems
      • 6.5.2.1.1 Robots/Robotic Automated Dispensing Systems
      • 6.5.2.1.2 Carousels
    • 6.5.2.2 Decentralized Automated Dispensing Systems (Ads)
      • 6.5.2.2.1 Pharmacy-Based Decentralized Automated Dispensing Systems
      • 6.5.2.2.2 Ward-Based Decentralized Automated Dispensing Systems
      • 6.5.2.2.3 Automated Unit-Dose Decentralized Automated Dispensing Systems
  • 6.5.3 Market Forecast
• 6.6 Assurance System
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Services

• 7.1 Medication Analytics Services
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Point-Of-Care Verification Services
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Adverse Drug Event (ADE) Surveillance Services
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Mode of Delivery

• 8.1 Web-based
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Cloud-based
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 On-premises
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by End User

• 9.1 Pharmacies
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Hospitals
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Allscripts Healthcare Solutions Inc.
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 ARxIUM Inc.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Becton Dickinson and Company
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 BIQ Health Solutions
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
  • 15.3.5 Cardinal Health Inc.
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
    • 15.3.5.3 Financials
    • 15.3.5.4 SWOT Analysis
  • 15.3.6 Mckesson Corporation
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
    • 15.3.6.3 Financials
    • 15.3.6.4 SWOT Analysis
  • 15.3.7 Omnicell Inc.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
    • 15.3.7.3 Financials
    • 15.3.7.4 SWOT Analysis
  • 15.3.8 Optum Inc. (UnitedHealth Group Incorporated)
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
  • 15.3.9 Oracle Corporation
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
    • 15.3.9.3 Financials
    • 15.3.9.4 SWOT Analysis
  • 15.3.10 Talyst LLC (Swisslog Healthcare)
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.